Table 5 Lipid parametersa in the all-exposed population (n = 4,009)
Parameter (mg/dl) | Baseline | Week 6 | Week 52b | Week 104 |
|---|---|---|---|---|
Mean total cholesterol | 196.2 (n = 3,714) | 227.6 (n = 3,279) | 222.9 (n = 1,312) | 224.1 (n = 828) |
Mean LDL cholesterol | 114.2 (n = 3,633) | 135.5 (n = 3,149) | 133.5 (n = 1,274) | 134.3 (n = 805) |
Mean HDL cholesterol | 56.9 (n = 3,656) | 60.8 (n = 3,249) | 60.0 (n = 1,301) | 60.0 (n = 826) |
Mean triglycerides | 127.6 (n = 3,715) | 160.4 (n = 3,280) | 148.8 (n = 1,312) | 148.8 (n = 828) |
Patients starting lipid-lowering medication at any time up to week 104 during the trial (n = 456) | ||||
Mean total cholesterol | 223.3 (n = 415) | 267.4 (n = 375) | 247.7 (n = 154) | 236.1 (n = 109) |
Mean LDL cholesterol | 135.1 (n = 402) | 167.6 (n = 338) | 152.9 (n = 142) | 138.9 (n = 97) |